TLR2 and acute myeloid leukemia: Subsequently, TLR2 induced the differentiation of monocytes into T-cell inhibitory myeloid-derived suppressor cells (MDSC), a type of immunosuppressive cell [96], resulting in a blockage of immune-response-mediated AML cell removal.